Evolus Statistics
Total Valuation
Evolus has a market cap or net worth of $312.43 million. The enterprise value is $423.80 million.
Important Dates
The next estimated earnings date is Tuesday, March 3, 2026, after market close.
| Earnings Date | Mar 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Evolus has 64.82 million shares outstanding. The number of shares has increased by 5.96% in one year.
| Current Share Class | 64.82M |
| Shares Outstanding | 64.82M |
| Shares Change (YoY) | +5.96% |
| Shares Change (QoQ) | +0.29% |
| Owned by Insiders (%) | 9.91% |
| Owned by Institutions (%) | 68.87% |
| Float | 46.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 339.44 |
| PS Ratio | 1.08 |
| Forward PS | 0.91 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.02
| Current Ratio | 2.02 |
| Quick Ratio | 1.41 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.88 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -10.60% |
| Return on Invested Capital (ROIC) | -18.16% |
| Return on Capital Employed (ROCE) | -24.99% |
| Weighted Average Cost of Capital (WACC) | 9.65% |
| Revenue Per Employee | $868,763 |
| Profits Per Employee | -$178,000 |
| Employee Count | 329 |
| Asset Turnover | 1.27 |
| Inventory Turnover | 3.99 |
Taxes
In the past 12 months, Evolus has paid $732,000 in taxes.
| Income Tax | 732,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.13% in the last 52 weeks. The beta is 0.92, so Evolus's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -66.13% |
| 50-Day Moving Average | 6.47 |
| 200-Day Moving Average | 7.94 |
| Relative Strength Index (RSI) | 27.86 |
| Average Volume (20 Days) | 1,438,274 |
Short Selling Information
The latest short interest is 6.79 million, so 10.47% of the outstanding shares have been sold short.
| Short Interest | 6.79M |
| Short Previous Month | 6.35M |
| Short % of Shares Out | 10.47% |
| Short % of Float | 14.63% |
| Short Ratio (days to cover) | 7.78 |
Income Statement
In the last 12 months, Evolus had revenue of $285.82 million and -$58.56 million in losses. Loss per share was -$0.91.
| Revenue | 285.82M |
| Gross Profit | 190.45M |
| Operating Income | -38.06M |
| Pretax Income | -57.83M |
| Net Income | -58.56M |
| EBITDA | -31.43M |
| EBIT | -38.06M |
| Loss Per Share | -$0.91 |
Full Income StatementBalance Sheet
The company has $43.52 million in cash and $154.89 million in debt, with a net cash position of -$111.37 million or -$1.72 per share.
| Cash & Cash Equivalents | 43.52M |
| Total Debt | 154.89M |
| Net Cash | -111.37M |
| Net Cash Per Share | -$1.72 |
| Equity (Book Value) | -28.76M |
| Book Value Per Share | -0.44 |
| Working Capital | 68.18M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$50.28 million and capital expenditures -$2.40 million, giving a free cash flow of -$52.68 million.
| Operating Cash Flow | -50.28M |
| Capital Expenditures | -2.40M |
| Free Cash Flow | -52.68M |
| FCF Per Share | -$0.81 |
Full Cash Flow StatementMargins
Gross margin is 66.63%, with operating and profit margins of -13.32% and -20.49%.
| Gross Margin | 66.63% |
| Operating Margin | -13.32% |
| Pretax Margin | -20.23% |
| Profit Margin | -20.49% |
| EBITDA Margin | -11.00% |
| EBIT Margin | -13.32% |
| FCF Margin | n/a |
Dividends & Yields
Evolus does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.96% |
| Shareholder Yield | -5.96% |
| Earnings Yield | -18.74% |
| FCF Yield | -16.86% |
Analyst Forecast
The average price target for Evolus is $18.80, which is 290.04% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.80 |
| Price Target Difference | 290.04% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 20.57% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Evolus has an Altman Z-Score of -1.38 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.38 |
| Piotroski F-Score | 2 |
